La Jolla Pharmaceutical Company announced the appointment of Darryl Wellinghoff as chief commercial officer.

“We are excited to welcome Darryl to La Jolla’s leadership team,” said George Tidmarsh, M.D., Ph.D., La Jolla’s president and chief executive officer. “Darryl brings extensive and highly relevant experience and depth of knowledge in sales, marketing, product launch and market access gained as a result of many successful product launches. He no doubt will help us continue fulfilling our mission of providing potentially life-saving therapies to patients in need.”

“La Jolla is developing life-saving products in areas of medicine that have had little innovation for decades, GIAPREZA is a great example of that. We have an incredible opportunity with GIAPREZA to impact the lives of patients and support our physician and hospital partners to deliver better outcomes for these complex patients,” said Mr. Wellinghoff. “I look forward to working with the team to execute a commercial strategy that drives results and fulfills the life-saving mission of the company.”